Yong Beom Choe
Konkuk University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yong Beom Choe.
Skin Research and Technology | 2007
Sang Hee Lim; Sang Min Kim; Yang Won Lee; Kyu Joong Ahn; Yong Beom Choe
Background/purpose: Ultraviolet (UV) irradiation affects the function and complexion of the skin by inducing changes in physical properties through formation of erythema, proliferation of epithelial cells, DNA damage, activation or inactivation of various enzymes and proteins, and free radical formation. In this study, the authors intended to observe the overall course of changes in barrier function and reflectance of the skin induced by photodamage, and healing reaction in the course of time, and alteration of the skin complexion.
Photodermatology, Photoimmunology and Photomedicine | 2003
Jai Il Youn; Je Young Park; Seong Jin Jo; Jong Hyun Rim; Yong Beom Choe
Background: Many reports have been released to assess skin types, skin colors and cutaneous sensitivity to broad band UVB or UVA.
Skin Research and Technology | 2006
Yong Beom Choe; Soo Jung Jang; Seong Jin Jo; Kyu Joong Ahn; Jai-Il Youn
Background/purpose: The assessment of the sensitivity of human skin to ultraviolet (UV) radiation is important in the area of phototherapy, photodermatoses, photo‐aging, photo‐carcinogenesis, and photo‐protection. Some reports have shown that quantitatively measured skin color is a good indicator for predicting UV sensitivity to human skin in Caucasians. In this study, our aim was to define the correlation between skin color and the skin phototype assessed by the Fitzpatrick method in Asian brown skin.
Annals of Dermatology | 2015
Sang Woong Youn; Bo Ri Kim; Joo Heung Lee; Hae Jun Song; Yong Beom Choe; Ji Ho Choi; Nack In Kim; Kwang Joong Kim; Jai Il Youn
Background The development of therapies for psoriasis has led to the need for a new strategy to the treatment of patients with moderate-to-severe psoriasis. New consensus guidelines for psoriasis treatment have been developed in some countries, some of which have introduced treatment goals to determine the timing of therapeutic regimens for psoriasis. Objective To investigate the opinions held by Korean dermatologists who specialize in psoriasis about treatment goals, and to compare these with the European consensus. Methods Korean dermatologists who specialize in psoriasis were asked 11 questions about defining the treatment goals for psoriasis. The questionnaire included questions about the factors used to classify the severity of psoriasis, defining the induction and maintenance phases of psoriasis treatment, defining treatment responses during the induction phase, and defining treatment responses during the maintenance phase. Results The Korean consensus showed responses that were almost similar to the European consensus, even without using the Delphi technique, which uses repeated rounds of questions to reach a consensus. Only one response that related to psoriasis severity in the context of the quality of patients lives differed from the European consensus. Conclusion The concept of using treatment goals in the treatment of moderate-to-severe psoriasis can be applied to Korean psoriasis patients. Since a tool for assessing the quality of patients lives is not commonly used in Korea, the development of a simple, rapidly completed, and region-specific health-related quality of life assessment tool would enable treatment goals to be used in routine clinical practice.
Clinical and Experimental Immunology | 2017
Soo Young Kim; Min Seok Hur; Bo-Ryoung Choi; Min Jung Kim; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Psoriasis is a polygenic and multi‐factorial disease showing ethnic differences in terms of its severity and frequency. Therapies targeting interleukin (IL)−17A, IL‐17 receptor (IL‐17R) and Janus kinases (JAKs) are in clinical development for the treatment of psoriasis, and their success suggests the essential role of these molecules in psoriasis. To investigate the genetic susceptibility in T helper type 17 (Th17) cell signal transduction pathways for promoting psoriasis, we performed candidate gene and linkage disequilibrium analysis. In 208 patients and 266 normal controls, we analysed 31 single nucleotide polymorphisms in 12 genes (CAMP, IL17A, IL17F, IL17RA, IL22, JAK1, JAK2, JAK3, STAT3, TLR7, TLR9 and TYK2; abbreviations: CAMP, human cathelicidin antimicrobial peptide; STAT‐3, signal transducer and activator of transcription 3; TLR, Toll‐like receptor; TYK2, tyrosine kinase 2). Patients with psoriasis showed a strong association for IL17F rs763780 [odds ratio (OR)u2009=u20093·27, Pu2009=u20090·04], which results in a histidine‐to‐arginine substitution, and JAK2 rs2274471 (ORu2009=u20092·66, Pu2009=u20090·02). In addition, JAK2 rs7849191 showed a protective pattern, met the significance threshold (ORu2009=u20090·77, Pu2009=u20090·05) and showed a tendency for an inverse association with the frequency of early‐onset psoriasis under age 40 years (Pu2009=u20090·07). In haplotype analysis, JAK1 rs310241A/rs2780889T showed a protective effect (ORu2009=u20090·73, Pu2009=u20090·03) in psoriasis. In conclusion, we report two new psoriasis‐susceptibility loci, in IL17F and JAK2, as well as a newly identified late‐onset associated protective JAK2 locus and a protective JAK1 haplotype in the Korean population.
Skin Research and Technology | 2013
Jae Wook Jung; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Even with the increasing demand for functional cosmeceuticals in the recent years, objective standard criteria for assessing their efficacy are currently incomplete at best. In this 8‐week face‐split study, in which we topically applied high‐priced cosmeceuticals on one side and more affordable cosmeceuticals on the other side of the face, we compared the efficacy of these two products using non‐invasive bioengineering technology.
Annals of Dermatology | 2017
Hae Jun Song; Chul Jong Park; Tae Yoon Kim; Yong Beom Choe; Seok-Jong Lee; Nack In Kim; Jae We Cho; Jie Hyun Jeon; Min Soo Jang; Jai Il Youn; Myung Hwa Kim; Joon Soo Park; Ki Ho Kim; Byung-Soo Kim; Sang Woong Youn; Joo Heung Lee; Min Geol Lee; Sung Ku Ahn; Young Ho Won; Seok Kweon Yun; Bong Seok Shin; Seong Jun Seo; Ji Yeoun Lee; Kwang Joong Kim; Young Suck Ro; Youngdoe Kim; Dae Young Yu; Jee Ho Choi
Background Psoriasis is an immune-mediated, chronic inflammatory disease affecting multiple aspects of patients lives. Its epidemiology varies regionally; however, nationwide epidemiologic data on psoriasis depicting profile of Korean patients has not been available to date. Objective To understand nationwide epidemiologic characteristics and clinical features of adult patients with psoriasis visited university hospitals in Korea. Methods This multicenter, non-interventional, cross-sectional study recruited 1,278 adult patients with psoriasis across 25 centers in Korea in 2013. Various clinical data including PASI, BSA, DLQI, SF-36 and PASE were collected. Results A total of 1,260 patients completed the study (male:female=1.47:1). The mean age was 47.0 years with a distribution mostly in the 50s (24.9%). Early onset (<40 years) of psoriasis accounted for 53.9% of patients. The mean disease duration was 109.2 months; mean body mass index was 23.9 kg/m2; and 12.7% of patients had a family history of psoriasis. Plaque and guttate types of psoriasis accounted for 85.8% and 8.4%, respectively. Patients with PASI ≥10 accounted for 24.9%; patients with body surface area ≥10 were 45.9%. Patients with DLQI ≥6 accounted for 78.8%. Between PASI <10 and PASI ≥10 groups, significant difference was noted in age at diagnosis, disease duration, blood pressure, waist circumference of female, and treatment experiences with phototherapy, systemic agents, and biologics. Conclusion This was the first nationwide epidemiologic study of patients with psoriasis in Korea and provides an overview of the epidemiologic characteristics and clinical profiles of this patient population.
Skin Research and Technology | 2018
M. J. Kim; W-J. Moon; M. S. Hur; S. H. Han; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Hyaluronic acid (HA) is an anionic, non‐sulfated glycosaminoglycan distributed throughout the human skin and injectable HA fillers are the most commonly used in aesthetic field. This study aimed to determine if differences in physical characteristics of HA products (monophasic or biphasic fillers) affect the patterns of magnetic resonance imaging (MRI).
Journal of The European Academy of Dermatology and Venereology | 2018
Sang Woong Youn; J. Lee; Dae Young Yu; Youngdoe Kim; Bongju Kim; Seong-Jun Seo; Yong Beom Choe; Seok Kweon Yun; Joon Soo Park; Nack In Kim; Chong Won Choi; J.I. Youn; Seok-Jong Lee; M. Lee; Kwang Joong Kim; Chul Jong Park; Young-Suck Ro; Hae Jun Song; Bong Seok Shin; S.K. Ahn; Ji Yeoun Lee; Young-Ho Won; Jang Ms; K.H. Kim; Mi-Kyung Kim; Tae-Won Kim; Jene Choi
Psychological aspect and quality of life should be considered in treating patients with psoriasis.
Journal of The European Academy of Dermatology and Venereology | 2017
J. Lee; Chul Jong Park; Tae-Won Kim; Yong Beom Choe; Nack In Kim; Hae Jun Song; J.-I. Youn; Sang Woong Youn; Jene Choi; Kwang Joong Kim
There is a lack of response data for topical treatments for psoriasis vulgaris in Asian patients.